We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-0.55%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$659M
AUM Growth
-$5.87M
Cap. Flow
-$2.63M
Cap. Flow %
-0.4%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$83.4M
2
CLDX icon
Celldex Therapeutics
CLDX
+$1.28M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$74.9M
2
INDA icon
iShares MSCI India ETF
INDA
+$6.43M
3
EPI icon
WisdomTree India Earnings Fund ETF
EPI
+$5.98M

Sector Composition

Rank Sector Weight
1 Healthcare 92.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$422M 64.06%
17,416,738
-2,812,975
-14% -$74.9M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$115M 17.46%
2,294,935
+1,728,935
+305% +$83.4M
ALKS icon
3
Alkermes
ALKS
$8.82B
$52.4M 7.95%
1,030,639
– –
CLDX icon
4
Celldex Therapeutics
CLDX
$2.77B
$18.1M 2.74%
420,847
+34,180
+9% +$1.28M
SPXU icon
5
ProShares UltraPro Short S&P 500
SPXU
$436M
$17M 2.58%
3,075
– –
SDS icon
6
ProShares UltraShort S&P500
SDS
$406M
$14.7M 2.23%
12,600
– –
EPI icon
7
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$10.1M 1.53%
400,000
-230,000
-37% -$5.98M
INDA icon
8
iShares MSCI India ETF
INDA
$6.71B
$9.53M 1.45%
290,000
-190,000
-40% -$6.43M

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q3 2017 Portfolio in Review

As of Q3 2017, Meditor Group held 8 positions worth $659M, down 0.88% from $665M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier.

  • Meditor Group added most to Esperion Therapeutics in Q3 2017, an estimated $83.4M increase.
  • Meditor Group's biggest Q3 2017 reduction was Exelixis, cutting an estimated $74.9M.
  • Meditor Group's ten largest holdings make up 100% of its $659M portfolio in Q3 2017.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2017.
  • Meditor Group's portfolio value fell 0.88% quarter-over-quarter to $659M.

Based on Meditor Group's 13F filing for Q3 2017, filed 17 Oct 2017.